Refine by
Phase 1 Clinical Equipment Supplied In Taiwan
4 equipment items found
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC599 is our proprietary BioSeizer® formulation of dexamethasone sodium phosphate (DSP) designed to provide sustained pain management for up to 24 weeks. TLC599 has the potential to enable patients to receive both immediate and sustained benefit from the local delivery of a highly potent and clinically validated steroid that typically has a very short half-life. Our clinical data suggests ...
Manufactured by:BRIM Biotechnology, Inc. based inTaipei City, TAIWAN
BRM423 is targeted to treat severe corneal damage. BRM423 is novel synthetic peptide derived from human Pigment Epithelium-Derived Factor (PEDF). Its active ingredient is the same as the BRM421 for Dry Eye Syndrome, but it is targeted to treat severe corneal damage. Based on BRIM’s proprietary PDSP technology platform, BRIM intends to rapidly advance development of this novel treatment for ...
by:Taiwan Liposome Company, Ltd. (TLC) based inNangang Distric, TAIWAN
TLC590 brings sustained release delivery technology to the common anesthetic ropivacaine, with the goal of reducing the frequency of administration for local anesthesia for post-surgical pain. More effective pain relief may also allow patients to avoid the problems of opioid therapies often used for the treatment of post-surgical pain.In a Phase I/II clinical trial in patients following hernia ...
Manufactured by:BRIM Biotechnology, Inc. based inTaipei City, TAIWAN
Novel drugs to relieve and repair tissue damage caused by osteoarthritis. BRIM Biotechnology is developing novel drugs to relieve and repair tissue damage caused by osteoarthritis. BRM521’s unique mechanism of action promotes joint cartilage regeneration and relieves ...